TME Pharma receives US FDA Fast Track designation for lead asset NOX-A12 in brain cancer
Fast Track designation awarded by the FDA serves as an external validation of the potential of NOX-A12 for unmet need in…
Fast Track designation awarded by the FDA serves as an external validation of the potential of NOX-A12 for unmet need in…
Sibanye-Stillwater, (Tickers JSE: SSW and NYSE: SBSW) (https://www.commodity-tv.com/...) in compliance with paragraphs…
Tauchen Sie ein in die faszinierende Welt des deutschen Gesundheitswesens und bleiben Sie auf dem neuesten Stand der akt…
Analog Devices, Inc. (Nasdaq: ADI) recently announced U.S. Food and Drug Administration (FDA) 510(k) clearance and the c…
Erhalten Sie einen exklusiven Einblick in die sich stetig entwickelnde Welt der Apotheken und des deutschen Gesundheitsw…
Corteco is aiming for further expansion in Southeast Europe. That is why the independent aftermarket unit of Freudenberg…
Financial highlights Direct MagnetOs sales grew by 163% to CHF 31.7 million in 2023, climbing from CHF 12.1 million…
Sibanye-Stillwater, (Tickers JSE: SSW and NYSE: SBSW) (https://www.commodity-tv.com/...) in compliance with paragraphs…
Clinical trial protocol approved in the US to initiate Phase 2 study with NOX-A12 in glioblastoma providing a clear road…
In an increasingly digitalized world in which technology and innovation are also revolutionizing the healthcare industry…